Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVernalis PLC Regulatory News (VER)

  • There is currently no data for VER

EGM Statement

30 Jun 2008 12:12

RNS Number : 8010X
Vernalis PLC
30 June 2008
 



30 June 2008

VERNALIS PLC

RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 30 JUNE 2008

Vernalis plc announces that all resolutions proposed to shareholders at the Extraordinary General Meeting held earlier today were duly passed.

All resolutions were approved on a show of hands. The number of proxy votes received for each resolution is set out below.

Resolution

For (including discretionary votes)*

Against*

Withheld

Ordinary Resolution

1. To approve the sale by the Company of Apokyn® and the US Commercial Operations

143,094,025

(99.98%)

25,322

(0.02%)

7,576

2. To increase the Company's authorised share capital and to authorise the Directors to allot relevant securities 

143,060,249

(99.98%)

28,285

(0.02%)

38,389

Special Resolution

3. To authorise the Directors to allot equity securities for cash without application of statutory pre-emption rights

142,665,007

(99.72%)

403,407

(0.28%)

58,509

*NB: Percentage of votes cast excludes withheld votes

Vernalis has forwarded to the Document Viewing Facility of the Financial Services Authority two copies of the resolutions passed at the Extraordinary General Meeting. These copies will shortly be available for viewing at the Document Facility, at the address below, from 9.00am to 5.30pm on every weekday except bank holidays.

Document Viewing Facility

The Financial Services Authority

25 The North ColonadeCanary Wharf

London E14 5HS

Tel: 020 7066 1000

Printed copies of the resolutions may be obtained by writing to The Company Secretary, Vernalis plc, Oakdene Court, 613 reading Road, Winnersh, Berkshire RG41 5UA.

Enquiries:

Vernalis plc +44 (0)118 977 3133

Tony Weir, Chief Financial Officer

Brunswick Group +44 (0)20 7404 5959

Jon Coles

Justine McIlroy

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
EGMBDLLLVQBLBBQ
Date   Source Headline
6th Mar 20125:29 pmRNSHolding(s) in Company
5th Mar 20125:39 pmRNSHolding(s) in Company
2nd Mar 20129:22 amRNSVoting Rights and Capital
28th Feb 201212:28 pmRNSResult of General Meeting
28th Feb 20127:00 amRNSResult of Open Offer
10th Feb 20124:53 pmRNSPublication of Combined Circular and Prospectus
10th Feb 20127:00 amRNSLicence Agreemt &Firm Placing &Placing &Open Offer
10th Feb 20127:00 amRNSVernalis and Tris Pharma Announce Collaboration
17th Jan 20127:00 amRNSVernalis & Servier Sign 3rd Oncology Collaboration
4th Jan 20127:00 amRNSVernalis enters collaboration with Genentech
19th Dec 20117:00 amRNSSecond Research Milestone Achieved
12th Dec 20117:00 amRNSVernalis Earns Final Milestone Payment from Ipsen
16th Nov 20117:00 amRNSInterim Management Statement
7th Nov 201111:43 amRNSHolding(s) in Company
3rd Oct 20117:00 amRNSMilestone Achieved and Collaboration Extended
28th Sep 20117:00 amRNSPositive Results for V158866 in Phase I Study
21st Sep 20117:00 amRNSResearch Milestone Achieved
8th Sep 20114:40 pmRNSSecond Price Monitoring Extn
8th Sep 20114:35 pmRNSPrice Monitoring Extension
24th Aug 20117:00 amRNSVernalis Initiates Phase I Trial of V81444
17th Aug 20115:16 pmRNSReplacement - Director/PDMR Shareholding
17th Aug 20114:35 pmRNSDirector/PDMR Shareholding
12th Aug 201110:00 amRNSDirector/PDMR Shareholding
5th Aug 201111:59 amRNSHolding(s) in Company
3rd Aug 20117:00 amRNSInterim results for six months ended 30 June 2011
3rd Aug 20117:00 amRNSAppointment of Non-Executive Director
2nd Aug 201111:30 amRNSVernalis Appoints Corporate Broker
22nd Jul 20117:00 amRNSNotice of Results for Six Months Ended 30 June '11
20th Jul 20117:00 amRNSAUY922 Update
5th Jul 20114:40 pmRNSSecond Price Monitoring Extn
5th Jul 20114:35 pmRNSPrice Monitoring Extension
15th Jun 201111:30 amRNSResult of AGM
8th Jun 20114:20 pmRNSHolding(s) in Company
26th May 20114:41 pmRNSSecond Price Monitoring Extn
26th May 20114:35 pmRNSPrice Monitoring Extension
26th May 20114:17 pmRNSListing Application, Voting Rights, Share Capital
23rd May 20114:58 pmRNSHolding(s) in Company
19th May 20114:40 pmRNSSecond Price Monitoring Extn
19th May 20114:35 pmRNSPrice Monitoring Extension
13th May 20117:00 amRNSTosedostat data to be presented at ASCO
11th May 20117:00 amRNSInterim Management Statement
6th May 20117:01 amRNSDirector/PDMR Shareholding
6th May 20117:00 amRNSDirector/PDMR Shareholding
4th May 20117:01 amRNSAnnual Information Update
4th May 20117:00 amRNSNotice of AGM
20th Apr 201111:57 amRNSHolding(s) in Company
12th Apr 20114:40 pmRNSSecond Price Monitoring Extn
12th Apr 20114:35 pmRNSPrice Monitoring Extension
12th Apr 20117:00 amRNSResults for the year ended 31 December 2010
12th Apr 20117:00 amRNSVernalis Regains A2A Receptor Antagonist Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.